Has Allison Wall, MD received payments from drug or device companies?

Yes. Drug and device makers reported $23,784 in general payments to Allison Wall, MD across 1,400 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Allison Wall, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Allison Wall, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Allison Wall, MD

Hematology & Oncology · Gulfport, MSNPI 1346446671

Payments from drug & device makers

$23,784in general payments, 2019–2025

Across 1,400 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
Merck$2K
AstraZeneca$1K
Johnson & Johnson$1K
Eisai Inc.$1K
Pfizer$943
plus $15K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	134	$2,071
Merck	85	$1,540
AstraZeneca(2 entities)	74	$1,362
Johnson & Johnson(2 entities)	102	$1,347
Eisai Inc.	77	$1,251
Pfizer	66	$943
Amgen	46	$843
Genentech USA, Inc.	60	$842
Exelixis Inc.	60	$839
Daiichi Sankyo Inc.	50	$817
Lilly USA, LLC	45	$802
E.r. Squibb & Sons, L.L.C.	51	$780
Bristol Myers Squibb	34	$728
Sanofi	33	$601
GSK	32	$571
Incyte Corporation	35	$554
Gilead(2 entities)	25	$553
Puma Biotechnology, Inc.	32	$462
Astellas Pharma US Inc	21	$394
Bayer	22	$370
Tersera Therapeutics LLC	15	$350
Ipsen Biopharmaceuticals, Inc	17	$338
Pharmaessentia USA Corporation	14	$289
Karyopharm Therapeutics Inc.	19	$289
Array Biopharma Inc	17	$288
Pharmacyclics LLC, An Abbvie Company	10	$273
Beigene USA, Inc.	13	$243
Takeda Pharmaceuticals U.S.A., Inc.	10	$219
Adaptive Biotechnologies Corporation	11	$217
Sanofi-aventis U.S. LLC	5	$209
Stemline Therapeutics Inc.	9	$188
Pharmacosmos Therapeutics Inc.	9	$185
Regeneron Healthcare Solutions, Inc.	10	$184
Taiho Oncology, Inc.	8	$162
Coherus Oncology, Inc.	9	$154
Emmaus Medical, Inc.	9	$152
Sobi, Inc	7	$151
Seagen Inc.	8	$134
EMD Serono, Inc.	8	$122
Rigel Pharmaceuticals, Inc.	7	$118
AbbVie	6	$117
Genmab U.S., Inc.	7	$117
Teva Pharmaceuticals USA, Inc.	7	$103
AVEO Pharmaceuticals, Inc.	5	$96
Jazz Pharmaceuticals Inc.	3	$94
Apellis Pharmaceuticals, Inc.	4	$89
Beone Medicines USA, Inc.	4	$78
Caris MPI, Inc.	4	$67
Boehringer Ingelheim	3	$61
Foundation Medicine, Inc.	3	$57
Clovis Oncology, Inc.	5	$54
Sanofi US Services Inc.	1	$54
Acceleron Pharma, Inc.	3	$50
Morphosys, US Inc.	3	$49
Geron Corporation	2	$46
Servier Pharmaceuticals LLC	2	$44
G1 Therapeutics, Inc.	3	$43
Mirati Therapeutics, Inc.	2	$41
Azurity Pharmaceuticals, Inc.	2	$36
Kyowa Kirin, Inc.	2	$36

How this compares

$23,784 in reported general payments places this provider in the 60th percentile of 57 hematology & oncology providers in Mississippi.

See all hematology & oncology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$584,049

Medicare patients

1,092

Services billed

5,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Gulfport

Pamela TuliGulfport$41K
Hamza MinhasGulfport$7K
Purushottam PandeGulfport$5K
Vibha Mishra-NicaudGulfport$1K
John HromHattiesburg$10M
Justin BakerJackson$2.1M
Solly ChedidPascagoula$1.7M
John HeneganJackson$1.2M
Carter MilnerJackson$261K
Andrew KellumTupelo$171K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →